eMed Technologies postpones IPO plans

Article

eMed Technologies postpones IPO plansTeleradiology and miniPACS provider eMed Technologies (formerly Access Radiology) surprised industry insiders by deciding to pull its initial public offering just as the IPO was preparing to issue (PNN

eMed Technologies postpones IPO plans

Teleradiology and miniPACS provider eMed Technologies (formerly Access Radiology) surprised industry insiders by deciding to pull its initial public offering just as the IPO was preparing to issue (

PNN

9/99). Citing a volatile market and Wall Street’s recent apprehension about Internet stocks and the healthcare information systems sector in particular, the Lexington, MA-based company opted to delay the offering until the climate improves, according to John Strauss, vice president of marketing.

“This is a postponement,” Strauss said. “We will continue to look at the marketplace, and when the healthcare segment is valued differently, we will consider doing this again.”

eMed had hoped to raise more than $57 million through the IPO by selling 3.1 million stocks at $12 to $14/share. Combined with existing private shareholder equity, this would have placed the company’s market capitalization at $177 million.

eMed’s plans to move in a more Internet-based direction remain unchanged, according to Strauss. The company introduced a Web-based teleradiology and image distribution application earlier this year and plans to debut a new Web-based service for radiologists at the upcoming RSNA meeting.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.